Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 30Lung Neoplasms 30Carcinoma, Non-Small-Cell Lung 26Leukemia, Myeloid, Acute 25Multiple Myeloma 22Breast Neoplasms 20Lymphoma 18Carcinoma, Renal Cell 17Urinary Bladder Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Myelodysplastic Syndromes 14Lymphoma, Large B-Cell, Diffuse 14Colorectal Neoplasms 14Pancreatic Neoplasms 11Neoplasm Metastasis 11Ovarian Neoplasms 10Myeloproliferative Disorders 10Mouth Neoplasms 10Glioma 10Glioblastoma 10Burkitt Lymphoma 10Squamous Cell Carcinoma of Head and Neck 9Triple Negative Breast Neoplasms 8Sarcoma 8Rectal Neoplasms 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Melanoma 8Lymphoma, Non-Hodgkin 8Laryngeal Neoplasms 8Carcinoma 8

Interventions

Cyclophosphamide 22Paclitaxel 12Epirubicin 12Doxorubicin 11Trastuzumab 10Docetaxel 10Carboplatin 10Taxes 7Bevacizumab 6pembrolizumab 5Radiotherapy 5Filgrastim 5Albumin-Bound Paclitaxel 5Neoadjuvant Therapy 4130-nm albumin-bound paclitaxel 4Thiotepa 3Tamoxifen 3Panitumumab 3Melphalan 3Lapatinib 3Granulocyte Colony-Stimulating Factor 3Fluorouracil 3Chemotherapy, Adjuvant 3sargramostim 2pertuzumab 2eribulin 2Radiation 2Peripheral Blood Stem Cell Transplantation 2Cisplatin 2Capecitabine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Inflammatory Breast Neoplasms × Specimen Handling × Clear all
NCT03598257 2026-05-13

Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
300 enrolled
Breast

Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡